Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

12/11 Early treatment study

Hussain et al., International Journal of Molecular and Immuno Oncology, doi:10.25259/IJMIO_30_2020 (Peer Reviewed)
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Source PDF Share Tweet

Small case study of ivermectin + doxycycline with 8 cancer patients, with all patients becoming PCR- by day 6 when tested again.

Hussain et al., 12/11/2020, peer-reviewed, 3 authors.

Details of all 63 studies Meta analysis

Please send us corrections, updates, or comments.

Submit